The independent source for health policy research, polling, and news.
1,141-1,160 of 1,316 results
With flawed systems for tracking the side effects of prescription drugs, a link between proton pump inhibitors and kidney disease suggested by research cannot be proven. Patients who swear by the drugs hope it won鈥檛 be.聽
Even the most exalted among us realize health care policy is complicated. Here's a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
A look at how and why strategic, star-studded advertising brought a drug for a little-known neurological condition into your home.
More than 70 drugs approved from 2001 through 2010 ran into safety concerns later that resulted in withdrawals from the market, 鈥渂lack box鈥 warnings or other actions.
Several public health officials endorse using a federal law to slash hepatitis C drug prices in Louisiana and avoid drug bills that could cripple the state budget.
Senior citizens have to be patient and keep close records to appeal when Medicare plans refuse to cover their medicines.
You might save money on premiums with a high-deductible health plan only to find you鈥檙e spending more on the back end. These tips will help you minimize your expenses for medical treatment and prescriptions.
Local health officials are bracing for the potential impact of a Trump administration policy that would stop federal funding to jurisdictions that don鈥檛 enforce federal immigration laws.
A California lawmaker wants to strengthen collaboration among public agencies to bring down costs to taxpayers.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
Even as drug pricing issues continue to draw scrutiny, federal safety regulations and incentives offer drug companies a new avenue to get a sweet return on their development costs.
With high drug prices creating widespread controversy, top pharmaceutical companies and their trade group vastly increased their lobbying spending on Capitol Hill.
Two companies that faced criticism for high-priced drugs, Marathon and Mallinckrodt, have dropped out of the PhRMA trade association.
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump鈥檚 inauguration, which earned them entry into private events with the president and vice president.
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry鈥檚 largest trade group.
The drugs, approved by the FDA for children earlier this month, can run $100,000 for a course of treatment.
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
Amplifying the "patient voice," those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.
Unlike heroin, fentanyl routinely shuts down breathing in seconds, and it's becoming more common.
漏 2026 KFF